Ehave, Inc. Utilizes Artificial Intelligence and Machine Learning for Big Data Management in Mental Healthcare
January 25, 2021 at 07:00 pm IST
Share
Ehave, Inc. announced plans to continue to address the needs of big data management in mental healthcare. The company has been using artificial intelligence and machine learning since the first version of its Ehave Dashboard to transform clinical research, identify treatment protocols, and increase the virtual care capabilities of health providers. Before the COVID-19 pandemic, Ehave began testing AI models for clinical and psychedelic researchers to perform predictive analysis about patient data. With COVID-19 cases still spreading rapidly as the virus mutates, many academic institutions and health systems have developed predictive technology to track the virus and simulate the risk of COVID-19 patients developing different symptoms. The Ehave Dashboard will continue to evolve to include its artificial intelligence and machine learning functions in order to become more integrated with clinical care in the coming years. Ehave Dashboard has been in the forefront of using data analytics with its blockchain data warehouse that provides insights to clinicians and patients. The health system continuously improves upon their system by layering on new tools, such as artificial intelligence and machine learning, bringing them closer to predictive analytics. The digital transformation among health systems was well underway when 2020 began. The COVID-19 pandemic underscored the need for centralized and efficient data management. The company has sped up development of data-gathering and reporting efforts during the pandemic, as well as cloud implementations to securely store and coordinate data. The use of BurstIQ enforces a strong cybersecurity in secure data storage.
Ehave, Inc. is a Canada-based company, which is an engaged in the digital therapeutics delivering evidence-based therapeutic interventions to patients. The Companyâs primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes. The Companyâs main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make decisions through data insights. The Companyâs Ehave Infinity Portal offers a machine learning and artificial intelligence platform with a growing set of tools and applications developed by the Company and its partners. This enables patients, healthcare providers and payers to address a range of conditions through data-driven involvement with the tools.